| Financial Year |
March 31 2023 |
| Monetary Funds |
330,580,707.17 |
| Held-for-trading Financial Assets |
47,119.02 |
| Notes Receivable |
54,350,732.40 |
| Accounts Receivable |
206,463,925.16 |
| Advances to Suppliers |
3,942,392.32 |
| Other Receivables |
2,148,659.06 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
227,227,863.11 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,421,654.12 |
| Total Current Assets |
899,495,979.79 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
12,610,601.33 |
| Fixed Assetes |
131,995,446.24 |
| Under-construction Projects |
1,307,672.08 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
20,639,062.90 |
| R&D expenses |
15,265,558.46 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
20,861,799.25 |
| Other Non-Current Assets |
7,770,729.47 |
| Sub-Total of Non-Current Assets |
233,487,318.55 |
| Total Assets |
1,132,983,298.34 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
124,252,851.73 |
| Accounts Payable |
262,957,403.37 |
| Accounts Received In Advance |
2,046,987.20 |
| Employee Compensation Payable |
6,621,073.83 |
| Taxes Payable |
1,069,405.72 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
45,895,981.90 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,371,790.15 |
| Other Current Liabilities |
9,617,710.58 |
| Sub-Total of Current Liabilities |
461,903,531.54 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
12,808,519.37 |
| Deferred Income Tax Liabilities |
433,835.43 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
63,166,736.16 |
| Total Liabilities |
525,070,267.70 |
| Paid-In Capital(Or Share Stock) |
141,516,450.00 |
| Capital Surplus |
89,117,475.01 |
| Surplus Reserve |
36,614,479.64 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
188,479,278.21 |
| Minority Stockholder's Interest |
144,781,224.68 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
463,131,805.96 |
| Owner's Equity（Stockholder's Equity） |
607,913,030.64 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,132,983,298.34 |
